Dance4Healing: Explore the Benefits of Tele-Dance in Individuals With an Implantable Cardioverter-defibrillator (ICD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04678128 |
|
Recruitment Status :
Withdrawn
(Not started)
First Posted : December 21, 2020
Last Update Posted : May 6, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| ICD Anxiety Patient Engagement | Behavioral: Dance4Healing Telehealth Live Zoom Sessions Behavioral: Dance Buddy | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 0 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Dance4Healing: A Pilot Study to Explore the Benefits of Tele-Dance in Individuals With an Implantable Cardioverter Defibrillator |
| Estimated Study Start Date : | January 1, 2020 |
| Actual Primary Completion Date : | December 31, 2020 |
| Actual Study Completion Date : | December 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Dance4Healing control group
Participants will monitor their heart rate for 8 weeks (pre-intervention period), then engage in weekly live zoom dance sessions on digital Dance4Healing platform for 8 consecutive weeks (intervention period), then may elect to continue with monitoring for an additional 12 weeks (3-month post-intervention period for long-term results). During the intervention period, this group will not have a dance buddy.
|
Behavioral: Dance4Healing Telehealth Live Zoom Sessions
Week 1: 2-hour introduction session on Zoom platform with a live dance instructor at the participant's desired level of activity intensity (low, mild, or moderate). Weeks 2-8: All participants will be asked to participate in a 1 hour online, instructor-led live class. |
|
Experimental: Dance4Healing Buddy Group
Participants will monitor their heart rate for 8 weeks (pre-intervention period), then engage in weekly live zoom dance sessions on digital Dance4Healing platform for 8 consecutive weeks (intervention period), then may elect to continue with monitoring for an additional 12 weeks (3-month post-intervention period for long-term results). During the intervention period, this group will have a dance buddy.
|
Behavioral: Dance4Healing Telehealth Live Zoom Sessions
Week 1: 2-hour introduction session on Zoom platform with a live dance instructor at the participant's desired level of activity intensity (low, mild, or moderate). Weeks 2-8: All participants will be asked to participate in a 1 hour online, instructor-led live class. Behavioral: Dance Buddy Following randomization (beginning of intervention period) half of the participants will be assigned a dance "buddy," and will be asked to dance with their buddies using the Dance4Healing TLVP at least 2 additional times/week. This group will have 24/7 access to Dance4Healing Platform during the intervention and post-intervention periods. |
- Activity in hours/day from ICD interrogation as a measure of activity engagement over time [ Time Frame: 36 weeks ]
- Change in calculated score from Patient Activation as a measure of Patient Activity Engagement over time [ Time Frame: Baseline, Week 8(pre-intervention), Week 16 (post-intervention), Week 28 (long term) ]Scores range from 0-100, higher scores represent higher engagement self reported survey
- Total Amount of Time spent accessing the dance platform in minutes as a measure of Activity Engagement during the study intervention [ Time Frame: Total time in minutes over the 8 week intervention period ]Total number of minutes that the participant accesses the Dance4Healing platform each week
- Change in Anxiety Score over time [ Time Frame: Baseline, Week 8(pre-intervention), Week 16 (post-intervention), Week 28 (long term) ]Anxiety will be a calculated score from a 10 question self-reported questionnaire (Florida Shock Anxiety Scale) with a scoring range from 0-50, with higher scores indicating more anxiety.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients that have had an ICD implanted for at least 1 month
- Patients have access to web-based on-line programs
- Patient can provide cardiac clearance for exercise from their treating physician OR they have written stress test results from within the last 6 months indicating no ischemia.
- Patient is 18 years old or greater.
Exclusion Criteria:
- Patient is non-English speaking.
- Patient is assessed as having NYHA Class IV heart failure.
- Patient had ventricular tachycardia (VT), ventricular fibrillation (VF) or has received "tachy" therapy from their ICD within last 4 weeks.
- Patient has had a change in medical arrhythmia management or ablation procedure within the last 4 weeks.
- Any medical issues that compromise walking or dancing, including cardiac, neurological or orthopedic .
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04678128
| United States, California | |
| Stanford Arrhythmia Clinic | |
| Stanford, California, United States, 94303 | |
| Principal Investigator: | Linda K Ottoboni, PhD | Stanford Healthcare |
| Responsible Party: | Sanjiv Narayan, MD, PhD, Professor of Medicine, Stanford University |
| ClinicalTrials.gov Identifier: | NCT04678128 |
| Other Study ID Numbers: |
IRB # 58348 |
| First Posted: | December 21, 2020 Key Record Dates |
| Last Update Posted: | May 6, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
ICD Anxiety QOL Engagement |

